Comparison of Two Doses of Edoxaban Using Different Tests (Assays) and Clinical Outcomes
Evaluation of Edoxaban in Anticoagulant Naïve Patients With Nonvalvular Atrial Fibrillation (NVAF) and High Creatinine Clearance
Sponsor: Daiichi Sankyo
A NA clinical study on Atrial Fibrillation, this trial is completed. The trial is conducted by Daiichi Sankyo and has accumulated 15 data snapshots since 2017. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
15 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Mar 2024 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Mar 2024 [monthly]
Completed NA
▶ Show 10 earlier versions
-
Mar 2019 — Jan 2021 [monthly]
Completed NA
-
Jan 2019 — Mar 2019 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jun 2018 — Jan 2019 [monthly]
Active Not Recruiting NA
-
Oct 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2017 — Oct 2017 [monthly]
Recruiting NA
-
Aug 2017 — Sep 2017 [monthly]
Recruiting NA
-
Jul 2017 — Aug 2017 [monthly]
Recruiting NA
-
Jun 2017 — Jul 2017 [monthly]
Recruiting NA
-
Mar 2017 — Jun 2017 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2017 — Mar 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Daiichi Sankyo
- Quintiles, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aalst, Belgium , Almería, Spain , Antwerp, Belgium , Baja, Hungary , Banská Bystrica, Slovakia , Barcelona, Spain , Bardejov, Slovakia , Barnaul, Russia , Belgrade, Serbia , Benešov, Czechia and 141 more locations